Product Name

  • Name

    Cabergoline

  • EINECS 200-419-0
  • CAS No. 81409-90-7
  • Article Data12
  • CAS DataBase
  • Density 1.156 g/cm3
  • Solubility
  • Melting Point 102-104°C
  • Formula C26H37N5O2
  • Boiling Point
  • Molecular Weight 451.612
  • Flash Point
  • Transport Information
  • Appearance White crystalline solid
  • Safety 26-36/37
  • Risk Codes 36/37/38
  • Molecular Structure Molecular Structure of 81409-90-7 (Cabergoline)
  • Hazard Symbols Xi
  • Synonyms Ergoline-8-carboxamide,N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-, (8b)- (9CI);Cabaser;Cabaseril;1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea;Ergoline-8beta-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propenyl)-;
  • PSA 71.68000
  • LogP 3.52270

Synthetic route

6-Norcabergoline
153415-36-2

6-Norcabergoline

Allyl acetate
591-87-7

Allyl acetate

cabergoline
81409-90-7

cabergoline

Conditions
ConditionsYield
tetrakis(triphenylphosphine) palladium(0) In toluene at 20℃; for 2h;92.3%
1-((6-allylergolin-8β-yl)-carbonyl)-1-(3-dimethylaminopropyl)-3-ethylurea chlorobenzene solvate

1-((6-allylergolin-8β-yl)-carbonyl)-1-(3-dimethylaminopropyl)-3-ethylurea chlorobenzene solvate

cabergoline
81409-90-7

cabergoline

Conditions
ConditionsYield
In n-heptane at 55℃; Product distribution / selectivity;90%
at 55 - 70℃; under 1.50015 Torr; for 24 - 92h; Product distribution / selectivity;
at 60℃; under 750.075 Torr; for 24h;
In diethyl ether; n-heptane at -35 - -15℃; for 8h; Product distribution / selectivity;
Cabergoline ethylbenzene/n-heptane

Cabergoline ethylbenzene/n-heptane

cabergoline
81409-90-7

cabergoline

Conditions
ConditionsYield
for 15h; Product distribution / selectivity; Drying under a blanket of nitrogen;86%
at 40℃; under 65.2565 - 83.2583 Torr; for 16 - 17h; Product distribution / selectivity;
at 60℃; for 20.5h; Product distribution / selectivity;
at 20 - 25℃; under 525.053 - 675.068 Torr; for 29.25h; Product distribution / selectivity; Vacuum;
at 40℃; for 2h; Product distribution / selectivity; Stream of nitrogen;
(6aR,9R,10aR)-7-allyl-N-[3-(dimethylamino)propyl]-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide
85329-86-8

(6aR,9R,10aR)-7-allyl-N-[3-(dimethylamino)propyl]-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide

ethyl isocyanate
109-90-0

ethyl isocyanate

A

cabergoline
81409-90-7

cabergoline

B

(6aR,9R,10aR)-7-allyl-N9-[3-(dimethylamino)propyl]-N4-ethyl-N9-(ethylcarbamoyl)-6a,7,8,9,10,10a-hexahydroindolo[4,3-fg]quinoline-4,9(6H)-dicarboxamide
126554-50-5

(6aR,9R,10aR)-7-allyl-N9-[3-(dimethylamino)propyl]-N4-ethyl-N9-(ethylcarbamoyl)-6a,7,8,9,10,10a-hexahydroindolo[4,3-fg]quinoline-4,9(6H)-dicarboxamide

Conditions
ConditionsYield
In toluene Heating;A 81%
B 0.57 g
(6aR,9R,10aR)-7-allyl-N-[3-(dimethylamino)propyl]-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide
85329-86-8

(6aR,9R,10aR)-7-allyl-N-[3-(dimethylamino)propyl]-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide

ethyl isocyanate
109-90-0

ethyl isocyanate

cabergoline
81409-90-7

cabergoline

Conditions
ConditionsYield
Stage #1: (6aR,9R,10aR)-7-allyl-N-[3-(dimethylamino)propyl]-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide With trimethylsilyl trifluoromethanesulfonate; triethylamine In dichloromethane at -2 - 18℃; for 14h;
Stage #2: ethyl isocyanate In dichloromethane at 18℃; for 48h;
Stage #3: With tetrabutyl ammonium fluoride In tetrahydrofuran; dichloromethane at -2℃; for 4h;
68.2%
1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride
25952-53-8

1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride

(6aR,9R,10aR)-7-allyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxylic acid
81409-74-7

(6aR,9R,10aR)-7-allyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxylic acid

A

cabergoline
81409-90-7

cabergoline

B

N-<<<3-(dimethylamino)propyl>amino>carbonyl>-N-ethyl-6-(2-propenyl)-ergoline-8β-carboxamide
81409-91-8

N-<<<3-(dimethylamino)propyl>amino>carbonyl>-N-ethyl-6-(2-propenyl)-ergoline-8β-carboxamide

Conditions
ConditionsYield
With triethylamine In dichloromethane at 0 - 25℃; for 20h; Product distribution / selectivity;A 54.7%
B n/a
With triethylamine In N,N-dimethyl-formamide Ambient temperature;A 46%
B 35%
With triethylamine In ethyl acetate at 20℃; Product distribution / selectivity;
tert-butyl (5R,8R,10R)-6-allyl-8-[[[3-(dimethylamino)propyl][(ethylamino)carbonyl]amino]carbonyl]ergoline-1-carboxylate
474397-69-8

tert-butyl (5R,8R,10R)-6-allyl-8-[[[3-(dimethylamino)propyl][(ethylamino)carbonyl]amino]carbonyl]ergoline-1-carboxylate

cabergoline
81409-90-7

cabergoline

Conditions
ConditionsYield
With hydrogenchloride In water at 80℃; for 1h;
methyl (6aR,9R,10aR)-7-allyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxylate
72821-79-5

methyl (6aR,9R,10aR)-7-allyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxylate

cabergoline
81409-90-7

cabergoline

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 85 percent / 2-hydroxypyridine / ethane-1,2-diol / 18 h / 100 °C
2: 92 percent / 4-(dimethylamino)pyridine / tetrahydrofuran / 2 h / 40 °C
3: NaHMDS / tetrahydrofuran / -40 - 20 °C
4: propan-2-ol / 18 h / 50 °C
5: aqueous hydrochloric acid / H2O / 1 h / 80 °C
View Scheme
Multi-step reaction with 2 steps
1: 85 percent / acetic acid / Heating
2: 81 percent / toluene / Heating
View Scheme
(6aR,9R,10aR)-7-allyl-N-[3-(dimethylamino)propyl]-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide
85329-86-8

(6aR,9R,10aR)-7-allyl-N-[3-(dimethylamino)propyl]-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxamide

cabergoline
81409-90-7

cabergoline

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 92 percent / 4-(dimethylamino)pyridine / tetrahydrofuran / 2 h / 40 °C
2: NaHMDS / tetrahydrofuran / -40 - 20 °C
3: propan-2-ol / 18 h / 50 °C
4: aqueous hydrochloric acid / H2O / 1 h / 80 °C
View Scheme
1-amino-3-(dimethylamino)propane
109-55-7

1-amino-3-(dimethylamino)propane

Boc-β-alanine-(4-carbonylaminomethyl)benzyl ester copoly(styrene-divinylbenzene)resin

Boc-β-alanine-(4-carbonylaminomethyl)benzyl ester copoly(styrene-divinylbenzene)resin

cabergoline
81409-90-7

cabergoline

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 85 percent / 2-hydroxypyridine / ethane-1,2-diol / 18 h / 100 °C
2: 92 percent / 4-(dimethylamino)pyridine / tetrahydrofuran / 2 h / 40 °C
3: NaHMDS / tetrahydrofuran / -40 - 20 °C
4: propan-2-ol / 18 h / 50 °C
5: aqueous hydrochloric acid / H2O / 1 h / 80 °C
View Scheme
tert-butyl (5R,8R,10R)-6-allyl-8-[[[3-(dimethylamino)propyl]amino]carbonyl]ergoline-1-carboxylate
474397-67-6

tert-butyl (5R,8R,10R)-6-allyl-8-[[[3-(dimethylamino)propyl]amino]carbonyl]ergoline-1-carboxylate

cabergoline
81409-90-7

cabergoline

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: NaHMDS / tetrahydrofuran / -40 - 20 °C
2: propan-2-ol / 18 h / 50 °C
3: aqueous hydrochloric acid / H2O / 1 h / 80 °C
View Scheme
tert-butyl (5R,8R,10R)-6-allyl-8-[[[3-(dimethylamino)propyl](phenoxycarbonyl)amino]carbonyl]ergoline-1-carboxylate
474397-68-7

tert-butyl (5R,8R,10R)-6-allyl-8-[[[3-(dimethylamino)propyl](phenoxycarbonyl)amino]carbonyl]ergoline-1-carboxylate

cabergoline
81409-90-7

cabergoline

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: propan-2-ol / 18 h / 50 °C
2: aqueous hydrochloric acid / H2O / 1 h / 80 °C
View Scheme
1-amino-3-(dimethylamino)propane
109-55-7

1-amino-3-(dimethylamino)propane

cabergoline
81409-90-7

cabergoline

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 85 percent / acetic acid / Heating
2: 81 percent / toluene / Heating
View Scheme
C29H45N5O2Si

C29H45N5O2Si

cabergoline
81409-90-7

cabergoline

Conditions
ConditionsYield
With ammonium fluoride In tetrahydrofuran; water
C32H51N5O2Si
909724-71-6

C32H51N5O2Si

cabergoline
81409-90-7

cabergoline

Conditions
ConditionsYield
With ammonium fluoride In methanol; water at 20℃; for 3h;
N-(3-dimethylaminopropyl)-N-ethylcarbodiimide
1892-57-5

N-(3-dimethylaminopropyl)-N-ethylcarbodiimide

(6aR,9R,10aR)-7-allyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxylic acid
81409-74-7

(6aR,9R,10aR)-7-allyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxylic acid

cabergoline
81409-90-7

cabergoline

Conditions
ConditionsYield
Stage #1: N-(3-dimethylaminopropyl)-N-ethylcarbodiimide; (6aR,9R,10aR)-7-allyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxylic acid In trifluoromethylbenzene (BTF) at 24 - 38℃;
Stage #2: With water; acetic acid In trifluoromethylbenzene (BTF) pH=5.0 - 5.5;
Stage #3: With potassium hydroxide In tert-butyl methyl ether; water pH=9.5 - 10.0;
1-((6-allylergolin-8β-yl)-carbonyl)-1-(3-dimethylaminopropyl)-3-ethylurea 2-chlorotoluene solvate

1-((6-allylergolin-8β-yl)-carbonyl)-1-(3-dimethylaminopropyl)-3-ethylurea 2-chlorotoluene solvate

cabergoline
81409-90-7

cabergoline

Conditions
ConditionsYield
at 30 - 60℃; under 0.750075 Torr; for 25h; Product distribution / selectivity;
1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride
25952-53-8

1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride

(6aR,9R,10aR)-7-allyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxylic acid
81409-74-7

(6aR,9R,10aR)-7-allyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxylic acid

cabergoline
81409-90-7

cabergoline

Conditions
ConditionsYield
Stage #1: 1-ethyl-(3-(3-dimethylamino)propyl)-carbodiimide hydrochloride; (6aR,9R,10aR)-7-allyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxylic acid With N-ethyl-N,N-diisopropylamine In N,N-dimethyl-formamide at 20℃; for 30h;
Stage #2: With ammonia; water In dichloromethane
tert-Amyl methyl ether
994-05-8

tert-Amyl methyl ether

cabergoline
81409-90-7

cabergoline

Form TAME cabergoline

Form TAME cabergoline

Conditions
ConditionsYield
Stage #1: tert-Amyl methyl ether; cabergoline at 41 - 50℃; for 0.25h;
Stage #2: cabergoline at 0 - 27℃; for 16.5h;
88.8%
4-(3-Aminopropyl)morpholine
123-00-2

4-(3-Aminopropyl)morpholine

cabergoline
81409-90-7

cabergoline

(5R,8R,10R)-6-allyl-N-[3-(morpholino)propyl]ergoline-8-carboxamide
1419268-44-2

(5R,8R,10R)-6-allyl-N-[3-(morpholino)propyl]ergoline-8-carboxamide

Conditions
ConditionsYield
at 65℃; for 144h; Inert atmosphere; Sealed tube;80%
at 65℃; for 144h; Inert atmosphere; Sealed tube;80%
cabergoline
81409-90-7

cabergoline

chlorobenzene
108-90-7

chlorobenzene

1-((6-allylergolin-8β-yl)-carbonyl)-1-(3-dimethylaminopropyl)-3-ethylurea chlorobenzene solvate

1-((6-allylergolin-8β-yl)-carbonyl)-1-(3-dimethylaminopropyl)-3-ethylurea chlorobenzene solvate

Conditions
ConditionsYield
In n-heptane at -20 - 20℃; for 1.25h;
n-heptane
142-82-5

n-heptane

ethylbenzene
100-41-4

ethylbenzene

cabergoline
81409-90-7

cabergoline

Cabergoline ethylbenzene/n-heptane

Cabergoline ethylbenzene/n-heptane

Conditions
ConditionsYield
Stage #1: ethylbenzene; cabergoline at -23 - 30℃; for 0.5h;
Stage #2: n-heptane at -23 - -17℃; for 3.66667h;
methanol
67-56-1

methanol

cabergoline
81409-90-7

cabergoline

methyl (6aR,9R,10aR)-7-allyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxylate
72821-79-5

methyl (6aR,9R,10aR)-7-allyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxylate

Conditions
ConditionsYield
With triethylamine
cabergoline
81409-90-7

cabergoline

(5R,8R,10R)-6-allyl-N-[3-(morpholino)propyl]-N-[(ethylamino)carbonyl]-ergoline-8-carboxamide
1419268-43-1

(5R,8R,10R)-6-allyl-N-[3-(morpholino)propyl]-N-[(ethylamino)carbonyl]-ergoline-8-carboxamide

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: sodium hydroxide / water; methanol
2: triethylamine / dichloromethane
View Scheme
Multi-step reaction with 3 steps
1: 144 h / 65 °C / Inert atmosphere; Sealed tube
2: dmap / tetrahydrofuran
3: isopropyl alcohol / 50 °C
View Scheme
cabergoline
81409-90-7

cabergoline

(6aR,9R,10aR)-7-allyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxylic acid
81409-74-7

(6aR,9R,10aR)-7-allyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline-9-carboxylic acid

Conditions
ConditionsYield
Stage #1: cabergoline With sodium hydroxide In methanol; water
Stage #2: With hydrogenchloride In methanol; water
cabergoline
81409-90-7

cabergoline

C37H46N4O6

C37H46N4O6

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 144 h / 65 °C / Inert atmosphere; Sealed tube
2: dmap / tetrahydrofuran
View Scheme
Togni's reagent
887144-97-0

Togni's reagent

cabergoline
81409-90-7

cabergoline

C27H36F3N5O2
1515864-84-2

C27H36F3N5O2

Conditions
ConditionsYield
With copper (I) acetate In methanol at 40℃; for 4.5h; Inert atmosphere;
cabergoline
81409-90-7

cabergoline

β‐cyclodextrin
7585-39-9

β‐cyclodextrin

C26H37N5O2*C42H70O35

C26H37N5O2*C42H70O35

Conditions
ConditionsYield
Stage #1: cabergoline; β‐cyclodextrin In methanol; water at 20℃; for 0.5h; Sonication;
Stage #2: In methanol; water at 20 - 50℃; for 48h;
cabergoline
81409-90-7

cabergoline

L-theanine cabergoline cocrystal

L-theanine cabergoline cocrystal

Conditions
ConditionsYield
In water; isopropyl alcohol

Cabergoline Chemical Properties

Molecular Structure of Cabergoline (CAS NO.81409-90-7):

Molecular Formula: C26H37N5O2
Formula Weight: 451.6
H bond acceptors: 7
H bond donors: 2
Freely Rotating Bonds: 8
Polar Surface Area: 71.68 Å2
Index of Refraction: 1.594
Molar Refractivity: 132.54 cm3
Molar Volume: 390.4 cm3
Surface Tension: 48.6 dyne/cm
Density: 1.156 g/cm3
Melting point: 102-104°C
InChI
InChI=1/C26H37N5O2/c1-5-11-30-17-19(25(32)31(26(33)27-6-2)13-8-12-29(3)4)14-21-20-9-7-10-22-24(20)18(16-28-22)15-23(21)30/h5,7,9-10,16,19,21,23,28H,1,6,8,11-15,17H2,2-4H3,(H,27,33)/t19-,21-,23-/m1/s1
Smiles
c12[C@@H]3[C@H]([N@@](C[C@@H](C3)C(N(C(NCC)=O)CCCN(C)C)=O)CC=C)Cc3c1c([nH]c3)ccc2
Product Categories: Intermediates & Fine Chemicals; Neurochemicals; Pharmaceuticals

Cabergoline History

 Cabergoline was invented by scientists working for the Italian drug company Farmitalia-Carlo Erba SpA in Milan in 1981/82, who were experimenting with semisynthetic derivatives of the ergot alkaloids. Farmitalia-Carlo Erba was acquired by Pharmacia in 1992, which in turn was acquired by Pfizer in 2002. The drug was not FDA approved until 2002. It went generic in late 2005 following US patent expiration.

Cabergoline Toxicity Data With Reference

Organism Test Type Route Reported Dose (Normalized Dose) Effect Source
mouse LD50 oral > 400mg/kg (400mg/kg)   European Journal of Medicinal Chemistry--Chimie Therapeutique. Vol. 24, Pg. 421, 1989.

Cabergoline Specification

  Cabergoline , with CAS number of 81409-90-7, can be called Ergoline-8-carboxamide,N-[3-(dimethylamino)propyl]-N-[(ethylamino)carbonyl]-6-(2-propenyl)-, (8b)- (9CI) ; Cabaser ; Cabaseril ; 1-((6-Allylergolin-8beta-yl)carbonyl)-1-(3-(dimethylamino)propyl)-3-ethylurea ; Ergoline-8beta-carboxamide, N-(3-(dimethylamino)propyl)-N-((ethylamino)carbonyl)-6-(2-propenyl)- . It is a white crystalline solid, used as a dopamine D2-receptor agonist. It is frequently used as a second-line agent in the management of prolactinomas when bromocriptine is ineffective.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View